INS and diabetes mellitus: In NOD mice, pharmacological inhibition of DHPS by administration of N1-guanyl-1,7-diaminoheptane (GC7) during the prediabetic stage resulted in improved glucose tolerance, greater insulin secretion, decreased immune infiltration of islets, and a delay of diabetes onset [26,27].